Cargando…
A real-world evidence of efficacy of palliative gastrectomy plus chemotherapy in metastatic gastric cancer patients
Background: The benefit of palliative gastrectomy for patients with metastatic gastric cancer (mGC) is controversial, and suitable candidates for surgery and treatment strategies remain unclear. The present study aimed to investigate the efficacy of palliative gastrectomy plus chemotherapy among pat...
Autores principales: | Yang, Lu-Ping, Wang, Zi-Xian, He, Ming-Ming, Wu, Hao-Xiang, Yuan, Shu-Qiang, Wang, Wei, Jin, Ying, Ren, Chao, Wang, Zhi-Qiang, Wang, Feng-Hua, Li, Yu-Hong, Wang, Feng, Xu, Rui-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504550/ https://www.ncbi.nlm.nih.gov/pubmed/31118812 http://dx.doi.org/10.2147/CMAR.S197052 |
Ejemplares similares
-
The survival benefit of palliative gastrectomy and/or metastasectomy in gastric cancer patients with synchronous metastasis: a population-based study using propensity score matching and coarsened exact matching
por: Yang, Lu-Ping, et al.
Publicado: (2019) -
Palliative gastrectomy plus chemotherapy versus chemotherapy alone for incurable advanced gastric cancer: a meta-analysis
por: Wu, Pei, et al.
Publicado: (2018) -
Phase II clinical trial of S‐1 plus nanoparticle albumin‐bound paclitaxel in untreated patients with metastatic gastric cancer
por: He, Ming‐ming, et al.
Publicado: (2018) -
Adjuvant Chemotherapy for Elderly Patients with Gastric Cancer after D2 Gastrectomy
por: Jin, Ying, et al.
Publicado: (2013) -
Comparison of Gemcitabine Plus Cisplatin vs. Docetaxel Plus Fluorouracil Plus Cisplatin Palliative Chemotherapy for Metastatic Nasopharyngeal Carcinoma
por: Sun, Xue-Song, et al.
Publicado: (2020)